Richard S. Makuch

451 total citations
6 papers, 333 citations indexed

About

Richard S. Makuch is a scholar working on Infectious Diseases, Ecology, Evolution, Behavior and Systematics and Surgery. According to data from OpenAlex, Richard S. Makuch has authored 6 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Ecology, Evolution, Behavior and Systematics and 1 paper in Surgery. Recurrent topics in Richard S. Makuch's work include Viral Infections and Vectors (2 papers), Viral Infections and Outbreaks Research (2 papers) and Vector-Borne Animal Diseases (2 papers). Richard S. Makuch is often cited by papers focused on Viral Infections and Vectors (2 papers), Viral Infections and Outbreaks Research (2 papers) and Vector-Borne Animal Diseases (2 papers). Richard S. Makuch collaborates with scholars based in United States. Richard S. Makuch's co-authors include C. J. Peters, Phillip R. Pittman, Joseph A. Mangiafico, Paul Gibbs, Timothy Lewis Cannon, Vicki A. Montgomery, J. Brown, Kevin Coonan, John C. Morrill and David J. McClain and has published in prestigious journals such as Radiology, Vaccine and Clinical Immunology and Immunopathology.

In The Last Decade

Richard S. Makuch

6 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard S. Makuch United States 5 267 152 89 42 38 6 333
Shanna Leventhal United States 10 298 1.1× 114 0.8× 94 1.1× 46 1.1× 69 1.8× 20 368
Qilin Xin China 10 228 0.9× 150 1.0× 59 0.7× 106 2.5× 46 1.2× 14 369
Psylvia Léger France 11 411 1.5× 198 1.3× 198 2.2× 107 2.5× 38 1.0× 13 584
Ronald von Possel Germany 9 250 0.9× 103 0.7× 96 1.1× 10 0.2× 14 0.4× 19 279
Yudai Kuroda Japan 10 191 0.7× 47 0.3× 58 0.7× 24 0.6× 39 1.0× 28 265
Brian D. Carey United States 11 256 1.0× 128 0.8× 14 0.2× 66 1.6× 47 1.2× 14 360
Agnieszka M. Szemiel United Kingdom 10 344 1.3× 98 0.6× 117 1.3× 68 1.6× 107 2.8× 13 478
Sherry Neff United States 7 198 0.7× 70 0.5× 74 0.8× 126 3.0× 31 0.8× 7 454
Stephen Findlay‐Wilson United Kingdom 7 298 1.1× 122 0.8× 143 1.6× 23 0.5× 25 0.7× 18 323
Evans E. Nkrumah Ghana 7 205 0.8× 58 0.4× 64 0.7× 10 0.2× 22 0.6× 13 288

Countries citing papers authored by Richard S. Makuch

Since Specialization
Citations

This map shows the geographic impact of Richard S. Makuch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard S. Makuch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard S. Makuch more than expected).

Fields of papers citing papers by Richard S. Makuch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard S. Makuch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard S. Makuch. The network helps show where Richard S. Makuch may publish in the future.

Co-authorship network of co-authors of Richard S. Makuch

This figure shows the co-authorship network connecting the top 25 collaborators of Richard S. Makuch. A scholar is included among the top collaborators of Richard S. Makuch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard S. Makuch. Richard S. Makuch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Pittman, Phillip R., David J. McClain, Kevin Coonan, et al.. (2015). Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans. Vaccine. 34(4). 424–429. 33 indexed citations
2.
Montgomery, Vicki A., et al.. (1999). The immunogenicity in humans of a botulinum type F vaccine. Vaccine. 18(7-8). 728–735. 18 indexed citations
3.
Pittman, Phillip R., Timothy Lewis Cannon, Richard S. Makuch, et al.. (1999). Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. Vaccine. 18(1-2). 181–189. 105 indexed citations
4.
Bender, G N & Richard S. Makuch. (1997). Double-contrast barium examination of the upper gastrointestinal tract with nonendoscopic biopsy: findings in 100 patients.. Radiology. 202(2). 355–359. 3 indexed citations
5.
Pittman, Phillip R., Richard S. Makuch, Joseph A. Mangiafico, et al.. (1996). Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine. 14(4). 337–343. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026